Literature DB >> 26666528

Evaluation of an Automated Chemiluminescent Immunoassay in Typing Detection of IgG Antibodies Against Herpes Simplex Virus.

Zhiyan Li1, Rong Yan1, Cunling Yan1, Ping Liu1, Zhenru Feng2.   

Abstract

BACKGROUD: Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are common infectious agents worldwide and the primary infection of HSV remains a major problem in the pregnant women in China nowadays. At present, typing detection of HSV is mainly based on ELISA in China.
METHODS: In this study, we evaluated the performance of a newly introduced chemiluminescent immunoassay assay (CLIA) for the determination of serum HSV-1 and HSV-2 immunoglobulin G (IgG) antibodies.
RESULTS: The functional sensitivity of detecting HSV-1 and HSV-2 IgG were 0.7 Index and 0.6 Index, respectively. The repeatability and the total imprecision coefficient of variations were both below 10%, and the recoveries of these assays ranged from 90% to 110%. High concentration of hemoglobin, lipids, and bilirubin in samples did not affect the results. The infective rates of HSV-1 and HSV-2 were 919 (87.5%) and 169 (16.1%), respectively. HSV-1 seroprevalence was significantly higher than that of HSV-2 (P < 0.001).
CONCLUSION: CLIA is an excellent method for HSV-1 and HSV-2 IgG measurement and can be used as a routine screening test. The infective rate of HSV was pretty high among women before pregnancy or in the period of pregnancy in Beijing.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  CLIA; HSV; methodology; seroprevalence

Mesh:

Substances:

Year:  2015        PMID: 26666528      PMCID: PMC6807222          DOI: 10.1002/jcla.21905

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  11 in total

1.  Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania.

Authors:  Mabula Joseph Kasubi; Arvid Nilsen; Howard S Marsden; Tomas Bergström; Nina Langeland; Lars Haarr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 2.  Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.

Authors:  A J Nahmias; F K Lee; S Beckman-Nahmias
Journal:  Scand J Infect Dis Suppl       Date:  1990

Review 3.  Herpes simplex virus-2 infection. An emerging disease?

Authors:  M Schomogyi; A Wald; L Corey
Journal:  Infect Dis Clin North Am       Date:  1998-03       Impact factor: 5.982

4.  The acquisition of herpes simplex virus during pregnancy.

Authors:  Z A Brown; S Selke; J Zeh; J Kopelman; A Maslow; R L Ashley; D H Watts; S Berry; M Herd; L Corey
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

5.  Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection.

Authors:  A Langenberg; J Benedetti; J Jenkins; R Ashley; C Winter; L Corey
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

6.  Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.

Authors:  W E Lafferty; L Downey; C Celum; A Wald
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

7.  Seroprevalence of HSV-1 and HSV-2 in Barbados.

Authors:  P N Levett
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

8.  Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations.

Authors:  F M Cowan; A M Johnson; R Ashley; L Corey; A Mindel
Journal:  BMJ       Date:  1994-11-19

9.  Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka.

Authors:  F M Cowan; R S French; P Mayaud; R Gopal; N J Robinson; S Artimos de Oliveira; T Faillace; A Uusküla; M Nygård-Kibur; S Ramalingam; G Sridharan; R El Aouad; K Alami; M Rbai; N P Sunil-Chandra; D W Brown
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

10.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Authors:  R G Pebody; N Andrews; D Brown; R Gopal; H De Melker; G François; N Gatcheva; W Hellenbrand; S Jokinen; I Klavs; M Kojouharova; T Kortbeek; B Kriz; K Prosenc; K Roubalova; P Teocharov; W Thierfelder; M Valle; P Van Damme; R Vranckx
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

View more
  1 in total

1.  Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region.

Authors:  Sangeeta Deka; Deepjyoti Kalita; Manisha Paul; Gaurav Badoni; Yogendra P Mathuria
Journal:  Cureus       Date:  2022-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.